HDAC6 and Familial prostate cancer: In this study, we devised and applied a virtual screening campaign on a large library of commercially available compounds, searching for molecules endowed with Hsp90/HDAC6 dual activity and antiproliferative activity against LNCaP and PC-3 prostate cancer cells.